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Abstract We used mRNA subtraction of differentiated and
dedifferentiated smooth muscle cells (SMCs) to reveal the
molecular mechanisms underlying the phenotypic modulation of
SMCs. With this approach, we found that a 10 kb mRNA
encoding a homotypic cell adhesion molecule, cadherin 6B, was
strongly expressed in differentiated vascular and visceral SMCs,
but not in the dedifferentiated SMCs derived from them. In vivo,
cadherin 6B was expressed in vascular and visceral SMCs, in
addition to brain, spinal cord, retina and kidney, at a late stage
of chicken embryonic development. These results suggest that
cadherin 6B is a novel molecular marker for vascular and visceral
SMC phenotypes and is involved in the late differentiation of
SMCs.
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1. Introduction
In serious diseases such as atherosclerosis, hypertension,
and leiomyogenic tumorigenicity, smooth muscle cells
(SMCs) display phenotypic modulation from a di¡erentiated
state to a dedi¡erentiated one [1]. Di¡erentiated SMCs have a
spindle-like shape and speci¢c intracellular structures includ-
ing well-developed dense membranes, dense bodies and myo-
¢brils and show ligand-induced contractility. In dedi¡erenti-
ated SMCs, these unique morphological and functional
properties are lost and the expression of SMC-speci¢c molec-
ular markers also disappears [2,3]. Several cytoskeletal and
contractile proteins can be used as SMC-speci¢c molecular
markers. Among them, caldesmon [4,5], calponin [6,7], K-tro-
pomyosin [5] and K1 integrin [8,9] are upregulated in di¡er-
entiated SMCs, but downregulated in dedi¡erentiated SMCs.
Alternative splicing events that result in the expression of
alternative isoforms of caldesmon [4,5], K-tropomyosin [5],
vinculin/metavinculin [10] and smooth muscle myosin heavy
chain [11,12] have been shown to be correlated with changes
in SMC phenotype. Until recently, the molecular mechanisms
underlying phenotypic modulation have not been well charac-
terized because of a lack of primary culture systems or cell
lines in which SMCs maintain a di¡erentiated phenotype. We
have recently established primary culture systems of vascular
and visceral SMCs that maintain a fully di¡erentiated pheno-
type under insulin-like growth factor-I (IGF-I)-stimulated
conditions [13,14]. Using these culture systems, we have clari-
¢ed that changes in the balance between the phosphatidylino-
sitol 3-kinase (PI3-K)/protein kinase B (PKB(Akt)) pathway
and the extracellular signal-regulated kinase (ERK) and p38
mitogen activated protein kinase (p38MAPK) pathways deter-
mine the phenotypes of vascular and visceral SMCs [14]. The
IGF-I signaling, which is mediated through the PI3-K/
PKB(Akt) pathway, is critically involved in maintaining the
di¡erentiated SMC phenotype, whereas the co-activation of
the ERK and p38MAPK pathways directly induces the dedif-
ferentiation of SMCs. In this study, we attempted to isolate
critical elements involved in the phenotypic modulation of
SMCs. For this purpose, we used mRNA subtraction of dif-
ferentiated and dedi¡erentiated SMCs and isolated cadherin
6B, whose expression is regulated in a phenotype-dependent
manner in vascular and visceral SMCs.
2. Materials and methods
2.1. Cell culture
SMCs were prepared for primary culture from 15-day-old chicken
embryo gizzards [13] and cultured on laminin-coated dishes under the
following conditions: IGF-I stimulated, IGF-I depleted and serum
stimulated. We used a monoclonal antibody against IGF-I (Upstate
Biotechnology) to deplete IGF-I from the SMC culture medium. This
antibody was able to neutralize the activity of the IGF-I secreted from
the SMCs and to induce dedi¡erentiation of the SMCs [13]. Vascular
SMCs from 15-day-old chicken aortae were prepared for primary
culture using the explant method, as described elsewhere [9].
2.2. RNA subtraction
Total RNA was isolated from cultured gizzard SMCs under the
three di¡erent conditions described above. mRNAs puri¢ed from
each source were reverse-transcribed. Single-stranded cDNAs thus
obtained were ampli¢ed by PCR using eight di¡erent arbitrary prim-
ers, according to the manufacturer’s recommended protocols (RNA-
image Kit 1, GenHunter) and separated by polyacrylamide gel elec-
trophoresis. cDNA fragments speci¢cally expressed in di¡erentiated
SMCs under IGF-I-stimulated conditions were selected and cloned.
To con¢rm that these cDNA fragments were present in the di¡er-
entiated but not the dedi¡erentiated cultured SMCs, we performed
virtual Northern blotting using a CapFinder PCR cDNA synthesis
kit (CLONTECH).
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2.3. Northern blotting
Total RNAs from all three sources were separated on 1.0% agarose-
formaldehyde denaturing gels and transferred to nylon membranes
(GeneScreenPlus, NEN Life Science Products). The blots were hybrid-
ized with the 32P-labeled antisense strands of the DD4 clone (one of
the clones obtained in the RNA subtraction), h-caldesmon-speci¢c
cDNA and with calponin cDNA, as described elsewhere [9]. To vis-
ualize 28S rRNAs, membranes were stained with 0.02% methylene
blue.
2.4. cDNA library screening
A cDNA library of gizzard SMCs from 15-day-old chicken embryos
was constructed in VZAPII and was screened by plaque hybridization
with a 32P-labeled cDNA fragment obtained by the mRNA subtrac-
tion, as described above. Three overlapping cDNA clones were ob-
tained and sequenced. To sequence the 5P-region, rapid ampli¢cation
of cDNA end (RACE) was performed.
2.5. In situ hybridization of chicken embryos
Chicken embryos were frozen on dry ice and sectioned 6^8 Wm
thick on a cryostat (Bright, UK). [35S]UTP-labeled riboprobes were
hybridized to the sections and analyzed by light microscopy [9]. Hy-
drolyzed riboprobes labeled with digoxigenin were prepared and hy-
bridized as described elsewhere [15]. After a high stringency wash,
ampli¢cation was performed using the TSA Plus (AP) System
(NEN Life Science Products, MA, USA) and £uorescent signals
were detected with HNPP/Fast Red (Boehringer Mannheim, Ger-
many). Images were obtained with a ZEISS Axiophot microscope.
2.6. Immunostaining and immunoblotting
Cryosections of aortae and gizzards from 15-day-old chicken em-
bryos were prepared and stained with a monoclonal antibody against
cadherin 6B, CCD6B-1 [16], which was kindly provided by Dr. M.
Takeichi (Graduate School of Science, Kyoto University, Japan). The
secondary antibody was conjugated with Alexa 488 (Molecular
Probes, USA). For immunoblotting, whole lysates of aortae and giz-
zards from 15-day-old chicken embryos were fractionated on a 7.5%
SDS^polyacrylamide gel and transferred onto nitrocellulose mem-
branes. The blots were incubated with anti-cadherin 6B, anti-caldes-
mon [17] or anti-calponin [18] antibodies and processed for chemilu-
minescence with the ECL detection kit (Amersham Pharmacia
Biotech).
3. Results
To better understand the molecular mechanisms underlying
the phenotypic modulation of SMCs, we carried out mRNA
subtraction of di¡erentiated and dedi¡erentiated gizzard
SMCs. In our ¢rst screening, we obtained 170 clones, which
were predominantly expressed in di¡erentiated SMCs. To se-
lect candidate genes from among these clones, we used virtual
Northern blotting to distinguish the cDNAs expressed in dif-
ferentiated and dedi¡erentiated SMCs and selected 48 positive
clones. We determined their sequences and chose 5 unique
clones. The 5P-RACE analyses revealed that two clones en-
coded partial sequences of adipoQ [19] and smooth muscle
type myosin heavy chain cDNAs [20], respectively. Among
the remaining three positive clones, we selected one that we
named DD4 (318 bp). DD4 is not homologous with any se-
quences registered at the BLASTN Search (NIH), the UniG-
ene database, or the human EST database, and we believed it
to be a part of the 3P-noncoding region of some cDNA.
Northern blotting analysis probed with DD4 revealed that a
10 kb mRNA is speci¢cally expressed in di¡erentiated gizzard
SMCs, but not in the serum-induced or the IGF-I depleted
dedi¡erentiated SMCs (Fig. 1, lanes 1 to 4). During serum-
stimulated dedi¡erentiation of SMCs, this mRNA rapidly de-
creased and completely disappeared after 3 days of culture.
This decrease coincided with the downregulation of h-caldes-
mon and calponin (Fig. 1, lanes 5 to 8).
To isolate the full-length cDNA encoding DD4, we
screened a cDNA library of gizzard SMCs by plaque hybrid-
ization. We obtained three overlapping cDNA clones (Fig. 2),
and found that these clones encoded partial sequences of the
chicken cadherin 6B cDNA [16]. However, none of them con-
tained the amino-terminal sequence. To obtain the full coding
sequence, we used the 5P-RACE method and were able to
acquire an additional 1200 bp (Fig. 2), which encoded the
amino-terminal sequence of cadherin 6B. The coding region
of this cDNA was identical with that of cadherin 6B. Based
on these results, we concluded that DD4 was actually derived
from the cadherin 6B mRNA. The length of the total cDNA
was 10 204 bp (from which the polyadenylation signal was
absent), which is in good agreement with the results from
our Northern blots and with the previously reported results
of Nakagawa and Takeichi [16].
Fig. 1. Expression of the DD4 mRNA in di¡erent phenotypes of
gizzard SMCs. The expressions of DD4 mRNA (¢rst panel; 10 kb)
in 15-day-old chicken embryo gizzards (lane 1) and cultured gizzard
SMCs (lanes 2 to 8) were compared with that of SMC-speci¢c mo-
lecular markers, h-caldesmon (second panel; 4.8 kb) and calponin
(third panel; 1.8 kb). Gizzard SMCs were cultured on laminin-
coated dishes under IGF-I-stimulated conditions (2 ng/ml IGF-I for
9 days; lane 2), IGF-I-deleted conditions (5 Wg/ml anti-IGF-I anti-
body for 9 days; lane 3) and serum-stimulated conditions (10%
FCS for 3 days; lane 4), respectively. Expression change of the
DD4 mRNA in cultured during serum-stimulated dedi¡erentiation
is shown in lanes 5 to 8: 1-day culture (lane 5), 2-day culture (lane
6), 3-day culture (lane 7), and 5-day culture (lane 8). The bottom
panel shows the 28S rRNA stained by methylene blue. An asterisk
indicates the positions of 28S rRNA in the top panel.
Fig. 2. Cloning of full-length DD4 cDNA. Alignment maps of DD4
cDNA and overlapping cDNA clones are schematically shown.
Original cDNA fragment obtained by mRNA subtraction is indi-
cated by a DD4 probe. The protein-coding region of DD4 cDNA,
which is completely identical with cadherin 6B, is indicated with a
closed box.
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It has been well documented that cadherin 6B is detected in
the invaginating neural plate and most strongly at the neural
crest during the emergence of neural crest cells from the neu-
ral tube in the chicken embryo [16]. However, the expression
of cadherin 6B in smooth muscle tissues has not been inves-
tigated. The results of our Northern blot analysis showed that
cadherin 6B mRNA was strongly expressed in the gizzard
muscle and signi¢cantly expressed in brain and aorta (Fig.
3). We further analyzed its mRNA expression in 15-day-old
chicken embryos by in situ hybridization using radiolabeled
riboprobes corresponding to the coding sequence of cadherin
6B. Fig. 4 shows that the cadherin 6B mRNA was co-ex-
pressed with h-caldesmon mRNA in smooth muscle tissues
such as aorta, gizzard and the digestive tract. In addition,
the cadherin 6B mRNA was de¢nitely detected in brain, spi-
nal cord, retina, and kidney. This result agrees with the results
of our Northern blotting analysis. We further analyzed the
detailed location of the cadherin 6B expression in the aorta
and gizzard by in situ hybridization using digoxigenin-labeled
riboprobes. The expression of the cadherin 6B transcript was
restricted to the medial SMC layer of the aorta and to the
SMC layer of the gizzard (Fig. 5). The cadherin 6B immuno-
staining was also localized to the SMC layer of the aorta and
gizzard (Fig. 6).
As shown in Fig. 1, the expression of cadherin 6B mRNA
in gizzard SMCs was regulated in a phenotype-dependent
manner. To address whether the cadherin 6B expression is
dependent on the vascular SMC phenotype, we compared
whole aortae, which are largely composed of di¡erentiated
vascular SMCs, with serum-induced dedi¡erentiated vascular
SMCs. The expression of cadherin 6B at the mRNA and
protein levels was coordinately downregulated with that of
h-caldesmon and calponin in dedi¡erentiated vascular SMCs
(Fig. 7A,B). These results indicate that the cadherin 6B ex-
pression is regulated in a phenotype-dependent manner in
vascular and visceral SMCs.
4. Discussion
The cadherin 6B cDNA was originally cloned from 2/3-day-
old whole chicken embryos by RT-PCR and the expression of
Fig. 4. Distribution of the cadherin 6B mRNA in 15-day-old chicken embryos. In situ hybridization was performed using [35S]UTP-labeled ri-
boprobes of cadherin 6B (panels A and C) and h-caldesmon (panels B and D). Sagittal sections of 15-day-old chicken embryos are presented.
Panels C and D are the magni¢ed regions of aorta in panels A and B. ao, aorta; br, brain; es, esophagus; ey, eye; gz, gizzard; kd, kidney; lu,
lung; pr, proventiculus and sp, spinal cord.
Fig. 3. Tissue-speci¢c expression of the cadherin 6B mRNA by
Northern blotting. Total RNAs were prepared from indicated tis-
sues and the cadherin 6B mRNA was analyzed (top panel). The
bottom panel shows the 28S rRNAs stained by methylene blue.
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cadherin 6B was well studied during neural crest development
[16,21]. In chicken embryos, cadherin 6B appears during early
neural tube formation. Its expression continues until neural
tube closure, but fades away when the neural crest cells mi-
grate from the neural tube. These studies clearly documented
the regulation of neural crest cell^cell adhesion by the cadher-
in protein family, but cadherin 6B expression in other tissues
or other developmental stages was not characterized. In this
study, we ¢rst demonstrated that cadherin 6B was expressed
in smooth muscle tissues such as aorta, gizzard and the diges-
tive tract, in addition to the brain, spinal cord, retina and
kidney at a late stage of chicken embryonic development. In
aorta and gizzard, cadherin 6B was detectable late in SMC
di¡erentiation (data not shown). Rat K-cadherin [22] and hu-
man cadherin 6 [23] are highly homologous with chicken cad-
herin 6B with 88 and 87% identity, respectively. It seems,
therefore, likely that chicken cadherin 6B is a family of these
proteins. However, K-cadherin is preferentially expressed in
fetal kidney but is not present in adult tissues [22], whereas
human cadherin 6 is intensely expressed in adult brain and
kidney, but not in smooth muscle tissues [23].
This paper provides the ¢rst demonstration that the vascu-
lar and visceral SMCs express cadherin 6B and that its ex-
pression is regulated in a SMC phenotype-dependent manner.
Since the IGF-I stimulation a¡ected the cadherin 6B expres-
sion, the signaling pathway mediated through PI3-K/
PKB(Akt) is likely to be responsible for upregulating the tran-
scription of its mRNA, as with other SMC molecular markers
such as caldesmon and calponin [13,14]. These ¢ndings sug-
gest that cadherin 6B is a novel molecular marker for the
SMC phenotype. Although we do not directly address the
function of cadherin 6B in SMCs, this protein might be in-
Fig. 6. Expression of the cadherin 6B protein in aorta and gizzard. The SMC layers in aorta and gizzard were stained with a monoclonal anti-
body against cadherin 6B (green). l, lumen; m, medial SMC layer of aorta; sm, SMC layer of gizzard. Bar, 100 Wm.
Fig. 5. Localization of the cadherin 6B mRNA in aorta and gizzard was analyzed by in situ hybridization using a digoxigenin-labeled probe.
The SMC layers in aortic media and gizzard were hybridized with antisense cadherin 6B probe (red). Nuclei in cells in both tissues were stained
with Hochest 33342. l, lumen; m, medial SMC layer of aorta; sm, SMC layer of gizzard. Bar, 100 Wm.
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volved in the cell^cell interactions of di¡erentiated SMCs or
in the late di¡erentiation processes of SMCs. Further analyses
are required to understand the biological signi¢cance of the
expression of cadherin 6B in SMCs.
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Fig. 7. Phenotype-dependent expression of cadherin 6B in vascular and gizzard SMCs. The expressions of cadherin 6B, h-caldesmon, and calpo-
nin mRNAs were analyzed by Northern blotting (A). The expression of cadherin 6B, caldesmon and calponin at a protein level was analyzed
by immunoblotting using a monoclonal antibody against cadherin 6B, anti-caldesmon antibodies and anti-calponin antibodies (B). Total RNAs
(A) or whole cell lysates (B) were isolated from aortae in 15-day-old chicken embryos (lane 1), dedi¡erentiated vascular SMCs under serum-
stimulated conditions (lane 2), di¡erentiated gizzard SMCs under IGF-I-stimulated conditions (lane 3) and dedi¡erentiated gizzard SMCs under
serum-stimulated conditions (lane 4). Anti-caldesmon antibodies recognized both h- and l-caldesmons, respectively.
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